Thyroid Disorder Market Report, Revenue, Trends, Competitive Landscape Study & Analysis, Forecast To 2030

 

The thyroid disorder market is projected to reach USD 2120 Million by 2030 at 3.30% CAGR during the forecast period 2022-2030.

Booming economies across the world is experiencing a radical shift to urbanization which, in a supple way, is creating a physiological disorder that is giving rise to the prevalence of various ailments. Diseases such as obesity, thyroid, autoimmune diseases are a common by-product of this shift and trigger thyroid disorders in many which, if not checked, in time can cause severe brain damage. The rising cases of thyroid disorder have become a concern for many initiating a collaborative agreement between private and public organizations to spread awareness. Efforts made by the pharmacies can be considered a tactical gambit in this context. As per the report of the International Thyroid Society, near about 20 million Americans are diagnosed with some form of thyroid disease, and around 12% can get affected by it in their lifetime. Chances of contracting the disease can aggravate if the patient has diabetes.

However, the treatment incurs high cost, and alternative treatment options are on the rise which can act as a headwind for the market. Side-effects of the treatment cannot be blind sighted as well. In considering the future of the market, this can seriously cause a plummeting effect.

Industry Trend:

New research by the University of Colorado School of Medicine Department of Radiation Oncology has revealed that thyroid tumors can be treated with stereotactic body radiation therapy (SBRT). The side-effects would be far lesser than the traditional method and the treatment promises the better chance of recovery. The University of Birmingham has recently called for universal testing for thyroid function to reduce the number of miscarriages and negative neurodevelopmental effects on the baby.

Segmentation:

The global thyroid disorder market report can be segmented by treatment, disease indication, route of administration and end-users.

By treatment, the market is segmented into drugs & supplements, diagnostics, and surgery.

Based on disease indication, the market includes hypothyroidism, hyperthyroidism, and others. The hypothyroidism holds the largest market share.

Based on the route of administration, the market encompasses oral, injectable, and others. High efficacy and bioavailability made the oral segment the most preferable.

On the basis of end-users, the market comprises hospitals and home use.

Regional Analysis:

Region-specific segmentation includes the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa.

The Americas are currently leading the pack with the maximum share of the market. North America is spearheading the region with a considerable number of patients and advanced technologies used in treating the disease in multiple facilities. Europe assumes the second position. However, the APAC is set to register the maximum CAGR during the forecast period as the region has two countries such as China and India which are showing considerable expansion. Market incumbents are also launching strategies to raise awareness among the populace which can further boost the sector’s revenue.

Market Competition:

The presence of several big shots across the globe is promising for the market as this will keep the market competitive and help it gain much from research and developments.

Some of the key players in this market are namely Allergan (Ireland), Abbott Laboratories (US), GlaxoSmithKline Plc (UK), Merck & Co., Inc. (US), Pfizer Inc. (US), RLC LABS (US), AbbVie (US), Mylan (US)and others.

Access Report @ https://www.marketresearchfuture.com/reports/thyroid-disorder-market-2747

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Doxorubicin Market Size, Revenue Analysis, Industry Outlook, Forecast Till 2030

Image
Doxorubicin is a type of chemotherapy medicine called an anthracycline. It is used to reduce or diminish the growth of cancer cells by blocking an enzyme called topo isomerase. Factors that are propelling the growth of the  doxorubicin market  are surge in geriatric population, rising prevalence of different types of cancer, increasing awareness for cancer treatment. According to the International Federation of Pharmaceutical Manufacturers & Associations, global pharmaceutical industry has spent more than USD 149.8 billion on pharmaceutical Research and development activities. The various side effects, cost containment policies by various governments, stringent regulatory environment for product approval, are likely to hinder market growth during the forecast period. Regional Analysis The American market is expected to dominate the global doxorubicin market during the forecast period due to the presence of major manufacturers, increase in number of cancer cases, awareness ...
Read more

Chromatography Software Market Size, Revenue Analysis, Industry Outlook, Forecast Till 2030

Image
According to MRFR analysis, the global  Chromatography Software Market  is expected to register a CAGR of ~8.1% from 2022 to 2030 and hold a value of USD 15,330 million by 2030. Chromatography software is the gadget that allows chromatography-based analysis. This software system organizes and manages data from chromatography instruments, records and processes it, and generates chromatograms and reports. Data processing, instrument control, and database management are automated using this chromatography data software. Chromatography informatics solutions are available in various formats, from integrated to automated independent software platforms. These tools are employed in multiple sectors, including materials science, drug development, and forensics. The growing demand for chromatography applications in different fields, surge in the utilization of chromatography techniques in R&D activities across various industries such as the pharmaceutical industry and increasing tec...
Read more

Orthokeratology Lens Market Revenue Trends, Company Profiles, Revenue Share Analysis Till 2030

Image
The   Orthokeratology Lens Market   is expected to reach USD 3,900.8 Million by 2030 at 7.8% CAGR during the forecast period 2022-2030. Orthokeratology is also known as ortho-k, corneal refractive therapy (CRT), and overnight vision correction therapy. In the orthokeratology therapy, rigid gas permeable contact lenses are worn overnight that reshapes the curvature of the cornea to improve object visibility. The use of ortho-k lenses eliminates the need for daytime contact lenses or glasses and improves vision. The increasing advancements in the field of ophthalmology over the past couple of decades, low cost compared to laser-assisted in situ keratomileuses (LASIK) treatment is anticipated to drive the market growth. However, the risk associated with orthokeratology and availability of alternative treatment methods is likely to hamper the market growth. Request Free Sample Copy at:  https://www.marketresearchfuture.com/sample_request/8218 Segment Analysis The global ortho...
Read more